CommercialCoverageMedium impact
08.02.47, linvoseltamab-gcpt (Lynozyfic™)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Oct 20, 2025
We identified it
Jun 19, 2026
Summary
A new pharmacy policy for linvoseltamab-gcpt (Lynozyfic™) has been established effective October 20, 2025. This appears to be coverage guidance for a new medication, likely requiring specific billing and authorization procedures.
Action Required
By October 20, 2025: Review the complete policy details at the provided URL to understand coverage criteria, prior authorization requirements, and billing procedures for linvoseltamib-gcpt (Lynozyfic™). Update billing system and staff training materials accordingly once full policy details are available.